摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-乙基香豆素 | 28045-77-4

中文名称
6-乙基香豆素
中文别名
——
英文名称
6-Ethylcoumarin
英文别名
6-ethylchromen-2-one
6-乙基香豆素化学式
CAS
28045-77-4
化学式
C11H10O2
mdl
——
分子量
174.2
InChiKey
SBZIILXFKTXDCJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • LogP:
    2.380 (est)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • 1-AMINO-PHTHALAZINE DERIVATIVES, THE PREPARATION AND THE THERAPEUTIC USE THEREOF
    申请人:Augereau Michel Jean
    公开号:US20070099895A1
    公开(公告)日:2007-05-03
    A 1-amino-phthalazine derivative of general formula (I) wherein the substituents are as defined herein. Also disclosed are a method for preparing such compounds, intermediates for use in such method and medical treatments using the compounds of formula (I).
    通用式(I)的1-基邻苯二酮衍生物,其中取代基如本文所定义。还披露了制备这类化合物的方法,用于该方法的中间体以及使用式(I)化合物进行医疗治疗的方法。
  • [EN] EZH2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS D'EZH2 ET LEURS UTILISATIONS
    申请人:DANA FARBER CANCER INST INC
    公开号:WO2016073956A1
    公开(公告)日:2016-05-12
    The present disclosure provides compounds of any one of Formulae (I) and (II). The compounds described herein are inhibitors of histone methyltransferases (e.g., enhancer of zeste homolog 1 (EZH1) and enhancer of zeste homolog 2 (EZH2)) and are useful in treating and/or preventing a broad range of diseases (e.g., proliferative diseases). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein. Further provided in the present disclosure are methods of identifying EZH1and/or EZH2 inhibitors.
    本公开提供了任一式(I)和(II)中的化合物。本文描述的化合物是组蛋白甲基转移酶抑制剂(例如增强子齿同源蛋白1(EZH1)和增强子齿同源蛋白2(EZH2)),可用于治疗和/或预防广泛范围的疾病(例如增生性疾病)。本公开还提供了包括或使用本文描述的化合物的药物组合物、试剂盒、方法和用途。本公开还提供了识别EZH1和/或EZH2抑制剂的方法。
  • CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND
    申请人:OSAKA UNIVERSITY
    公开号:US20170052449A1
    公开(公告)日:2017-02-23
    A pattern-forming method comprises patternwise exposing a predetermined region of a resist material film made from a photosensitive resin composition comprising a chemically amplified resist material to a first radioactive ray that is ionizing radiation or nonionizing radiation having a wavelength of no greater than 400 nm. The resist material film patternwise exposed is floodwise exposed to a second radioactive ray that is nonionizing radiation having a wavelength greater than the wavelength of the nonionizing radiation for the patternwise exposing and greater than 200 nm. The chemically amplified resist material comprises a base component, and a generative component that is capable of generating a radiation-sensitive sensitizer and an acid upon an exposure. The generative component comprises a radiation-sensitive sensitizer generating agent. The radiation-sensitive sensitizer generating agent comprises a compound represented by formula (A).
    一种图案形成方法包括将一种化学放大型光刻胶材料制成的感光树脂组成物的预定区域图案暴露于第一种放射性射线中,该放射性射线是电离辐射或波长不大于400 nm的非电离辐射。图案化暴露的光刻胶材料膜被洪式暴露于第二种放射性射线中,该放射性射线是波长大于图案化暴露的非电离辐射的波长和大于200 nm的非电离辐射。该化学放大型光刻胶材料包括基础组分和能够在暴露时生成辐射敏感的敏化剂和酸的生成组分。生成组分包括辐射敏感的敏化剂生成剂。辐射敏感的敏化剂生成剂包括由式(A)表示的化合物。
  • Indole Sulfonamide Modulators of Progesterone Receptors
    申请人:Bleisch Thomas John
    公开号:US20090069400A1
    公开(公告)日:2009-03-12
    Compounds of Formula (I), wherein n is 1 or 2, and R1, R2, R3, R4, R5, R6, R7, and R8 are as defined herein, their preparation, pharmaceutical compositions, and methods of use are disclosed.
    本发明揭示了化学式(I)的化合物,其中n为1或2,R1、R2、R3、R4、R5、R6、R7和R8如本文所定义,其制备方法、药物组合物及使用方法。
  • A process for producing octahydrocoumarins and same as a product of such process
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:EP0757989A1
    公开(公告)日:1997-02-12
    The present invention involves the production of octahydrocoumarins from coumarins and/or 3,4-dihydrocoumarins in good yields by a simple process which can be industrially carried out by reducing coumarins and/or 3,4-dihydrocoumarins to octahydrocoumarins with hydrogen in the presence of an alcohol and a ruthenium catalyst, and optionally heating resultant 3-(2-hydroxycyclohexyl) propionate contained in the reduction reaction mixture to conduct cyclization/dealcoholization and convert same to octahydrocoumarins.
    本发明涉及以香豆素和/或 3,4-二氢香豆素为原料生产八氢香豆素,产率高,工艺简单、4-二氢香豆素在醇和催化剂存在下用氢气还原成八氢香豆素,并可选择加热还原反应混合物中所含的 3-(2-羟基环己基)丙酸酯,以进行环化/脱醇反应并将其转化成八氢香豆素
查看更多